ERBB2 and breast cancer: In multinomial logistic regression models evaluating the odds of BC molecular subtypes compared with controls (Table 4), high hsCRP (> 3.0 mg/L) was statistically significantly associated with increased odds of luminal A (aOR: 4.03; 95% CI: 1.29, 12.64), TN (aOR: 3.32; 95% CI: 1.07, 10.35), and HER2-enriched (aOR: 6.27; 95% CI: 1.69, 23.25) BC subtypes.